Key vendors to strategically increase their sales by focusing on generic drugs
Technavio, a company that develops over 2000 pieces of research every year and covers more than 500 technologies across 80 countries, has announced the top five leading vendors for the global erectile dysfunction market in their latest research report. This report also lists 11 other prominent vendors who are expected to contribute to this market’s growth between 2016-2020.
To identify the top vendors, Technavio’s market research analysts have taken into account the revenue generated by the sale of different types of penile implants, ED creams, and drugs, including branded and generic drugs.
- Inflatable penile implant: This comprises of two-piece and three-piece penile implants.
- Semi-rigid/malleable rod implant: This includes silicone non-malleable penile implants with four zones of stiffness.
This Technavio report, under health and wellness vertical, is based on the synthesis, analysis, and interpretation of information about the global erectile dysfunction market collected from specialized sources. The analysts have derived insights using a mix of primary and secondary research with an aim to provide a holistic picture of the market.
Click here to request a free sample of this report
Competitive vendor landscape
Various diseases including hormonal insufficiency, diabetes, chronic disorders, renal diseases, hypertension, and various neurological disorders are increasing the demand for these products in the market. Competition in the market is very intense due to the presence of different established players. The companies are also investing in research to develop more effective therapies to increase their sales and profitability. Additionally, vendors are offering a variety of solutions for ED that includes ED drugs, ED devices or implants, intraurethral injections, and vacuum erection devices to attract more consumers. The companies are focusing on APAC countries such as China, South Korea, and Japan to increase their global footprint and meet the increase consumer requirements in the region. The vendors in the market compete on the basis of price, availability, brand, and variety.
“The manufacturers in the market are focusing on product innovations pertaining to penile implants to increase their market share and sustain the level of competition in the market. The vendors are innovating product technology to make ED solutions such as penile implants more reliable and natural-looking. Some of these technologically advanced products provide maximum girth and rigidity and help in reducing the overall weight of the implant. Companies are also concentrating on developing solutions that make them more effective, work rapidly, and reduce or eliminate side effects,” says Amber Chourasia, a lead analyst at Technavio for research on health and wellness.
Top five vendors in the erectile dysfunction market space
Bayer
The company focuses on R&D, production and sales of drugs, pharmaceuticals, vaccines, antibiotics, and small components for human and animal health across the globe. The company’s men’s health business unit offers products for the treatment of erectile dysfunction in men. Recently, it acquired Dihon Pharmaceutical, a China-based privately held pharmaceutical company specializing in OTC dermatology products and herbal traditional Chinese medicine products for various women’s health indications.
Key product: Staxyn.
Boston Scientific
The company designs, develops, produces, and markets a wide range of medical devices, which are utilized in various interventional medical specialties, including cardiac rhythm management, interventional cardiology, electrophysiology, endoscopy, peripheral interventions, urology, women’s health, and neuromodulation.
Key products: AMS 700 penile implant, AMS Ambicor penile implant, and Spectra concealable penile implant.
Coloplast
Coloplast manufactures products for the treatment of ostomy, incontinence, mastectomy, wounds, and skin diseases and it serves hospitals, medical institutions, wholesalers, and pharmacies. The company offers moldable rings, belts, strip pastes, elastic tapes, adhesive remover sprays and wipes, skin barrier sprays and wipes, protective sheets, barrier creams, and skin powders.
Key products: Titan Touch inflatable penile prosthesis and Genesis Malleable penile prosthesis.
Eli Lilly
The company discovers, develops, and markets a wide range of human and animal healthcare products. It offers medicines for cardiovascular conditions, diabetes, cancer, neurological problems, critical care, men’s health, and musculoskeletal problems. Recently, it entered into an agreement with Sanofi to pursue regulatory approval of nonprescription Cialis.
Key products: Cialis.
Pfizer
Pfizer produces, manufactures, and develops different pharmaceutical products for various therapy areas including arthritis, cardiovascular conditions, metabolic disorders, infectious diseases, and respiratory problems. Recently, the company announced that FDA has approved the first-ever generic version of Viagra.
Key products: Viagra.
Other prominent vendors in this market include Apricus Biosciences, Cristalia Produtos Quimicos Farmaceuticos, Dong-A Socio, Endo Pharmaceuticals, Futura Medical, Meda Pharmaceuticals, Promedon, SK Chemical, Teva Pharmaceuticals, Vivus, and Zephyr Surgical Implants (ZSI).
A more detailed analysis is available in the Technavio report, Global Erectile Dysfunction Market 2016-2020. Technavio also customizes reports by other regions and specific segments upon request.
To read more press releases- click here.
Browse related reports:
- Global Premature Ejaculation Treatment Market 2016-2020
- Sexual Wellness Market in the US 2016-2020
- Global Adult Vibrator Market 2016-2020
For any assistance or query, please contact our media team at:
media@technavio.com
US: +1 630 333 9501
UK: +44 208 123 1770
www.technavio.com
